Skip to Main Content

GLP-1 Weight Loss Medications

GLP-1 Weight Loss in Covington, Louisiana

Tirzepatide, semaglutide, and retatrutide (RETA) with ongoing medical oversight.

At a Glance

  • Tirzepatide (Mounjaro / Zepbound)
  • Semaglutide (Ozempic / Wegovy)
  • Retatrutide (RETA)
  • Medical monitoring and integrative wellness support

Overview

Our GLP-1 weight loss program offers tirzepatide, semaglutide, and retatrutide (RETA) under licensed medical supervision in Covington, Louisiana. We take a personalized approach that considers your metabolism, lifestyle, mental health, and medical history to determine the most effective GLP-1 medication plan. Ongoing monitoring and integrative support help you achieve sustainable, whole-body results.

Clinical & Technical Details

GLP-1 Receptor Agonists: Mechanism of Action

GLP-1 (glucagon-like peptide-1) is an incretin hormone released after eating. GLP-1 receptor agonists bind to these receptors in the pancreas, brain, and GI tract, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite via hypothalamic signaling. Tirzepatide adds GIP receptor activation, which may further influence fat metabolism and insulin sensitivity.

Common Side Effects and Management

The most common side effects are gastrointestinal (nausea, vomiting, diarrhea, and constipation), especially during dose escalation. These often improve over time. We use gradual titration schedules and dietary guidance to minimize discomfort. Report persistent vomiting, severe abdominal pain, or signs of allergic reaction promptly.

Integrative Weight Loss at Reintegration Wellness

GLP-1 medications work best as part of a whole-body plan. We consider your mental health, hormones, sleep, and nutrition alongside medication selection. This integrative approach supports sustainable results rather than short-term weight reduction alone.

Frequently Asked Questions

Common questions about glp-1 weight loss medications at Reintegration Wellness in Covington, Louisiana.

We offer tirzepatide (Mounjaro / Zepbound), semaglutide (Ozempic / Wegovy), and retatrutide (RETA) under licensed medical supervision. Your provider will recommend the option best suited to your medical history, goals, and tolerance.
Both are GLP-1 receptor agonists used for weight management, but they work differently. Semaglutide primarily activates GLP-1 receptors. Tirzepatide is a dual GIP/GLP-1 receptor agonist, which may provide additional metabolic effects for some patients. Your provider will help determine which medication aligns with your health profile.
Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors. It is an emerging option in the GLP-1 weight loss space and may be considered for appropriate candidates under close medical monitoring. Availability and candidacy depend on individual assessment.
GLP-1 medications work by mimicking incretin hormones that regulate appetite, slow gastric emptying, and improve blood sugar control. Most patients experience reduced hunger and improved satiety, which supports sustainable calorie reduction when combined with lifestyle changes.
Candidates typically include adults with obesity or overweight with related health conditions, as determined by BMI and medical history. We screen for contraindications including certain thyroid conditions, pancreatitis history, pregnancy, and active gallbladder disease before starting treatment.
We monitor weight progress, side effects, blood sugar if applicable, and overall wellness throughout your program. Dosing is typically started low and titrated gradually to minimize nausea and GI side effects. Regular follow-up visits ensure your plan remains safe and effective.

Ready to Get Started?

Schedule a consultation for glp-1 weight loss medications. Our team will review your history and help determine the right next step for you.

View All Services

Call Us985.234.9973